Speaker: Dr. Ronald A. Booth, BSc, MSc, PhD, DCC, FCACB, FADLM  
BSc & MSc (Biochemistry, Carleton University) 
PhD (Biochemistry & Molecular Biology, University of Ottawa) 
Post-Doctoral Diploma in Clinical Chemistry (University of Toronto) 
Certified Clinical Chemist 
Fellow of the Canadian Academy of Clinical Biochemists 
Fellow of the American Association for Diagnostics & Laboratory Medicine 
Clinical Biochemist, The Ottawa Hospital & Eastern Ontario Regional Laboratory Association 
Full Professor, Department of Pathology & Laboratory Medicine, University of Ottawa 
Founder and Past Chair of the Canadian Society of Clinical Chemists – Monoclonal Gammopathy Working Group.  

This webinar will take you inside the “black box” of laboratory medicine to understand how vitally important it is to patient care. We will focus specifically on multiple myeloma related testing. Greater than 70% of all medical decisions are based on laboratory medicine test results and this is no different with multiple myeloma. Without laboratory results, many conditions could not be accurately diagnosed or treated, including multiple myeloma. We will delve into how the laboratory doctors, technologists and technicians transform blood, urine and tissues into understandable result that treating doctors and nurses use to diagnose and monitor patients. We will explore the laboratory methods used and how they are interpreted in multiple myeloma; including protein electrophoresis, immunofixation, serum free light chains, complete blood count, immunoglobulin (IgG, IgA, IgM) measurement, flow cytometry and bone marrow biopsy. By the end of the session, you will have greater understanding and appreciation of how laboratory medicine works in multiple myeloma. 

Register here